# Risk: __Underreporting of infections__ (PBN__Risk_586)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [diagnostic testing technologies](../Technology/PBN__Technology_1309)
* [serological testing technologies](../Technology/PBN__Technology_1310)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskISO_Purpose

* [Health and care](../RiskISO/PBN__RiskISO_Impact_3)

## Property: has_RiskOwner

* [healthcare providers](../Stakeholder/PBN__Stakeholder_121)
* [researchers](../Stakeholder/PBN__Stakeholder_2)

## Property: has_RiskMitigation

* [Back-calculation of infections from observed deaths](../RiskMitigation/PBN__RiskMitigation_823)
* [Improve testing frequency and accuracy, conduct seroprevalence surveys.](../RiskMitigation/PBN__RiskMitigation_2514)

## Property: has_RiskName

Inaccurate understanding of the true infection rate and potential for re-infections.

## Property: has_RiskDescription

Seroprevalence surveys suggesting a higher number of infections compared to reported cases.

## Property: has_RiskSource

* [pilz_contributions_2022](../Article/PBN__Article_245)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskHealth

* [nan](../RiskHealth/PBN__RiskHealth_6)

